Indian Anti-Diabetic Pharma Market is Largely Driven by Huge Diabetic Patient Base, Finds Netscribes

Netscribes (India) Pvt. Ltd., launches a report on the Anti-Diabetic Pharmaceuticals Market in India 2012 as part of Netscribes’ Healthcare Industry report series.

Mumbai, India, April 01, 2012 --( Netscribes (India) Pvt. Ltd., a knowledge consulting solutions company, announces the launch of its Anti-Diabetic Pharmaceuticals Market in India 2012 report. India being the second largest diabetic pool in the world, the market is expected to show steady growth in the coming years.

The report begins with the introduction section which offers a brief classification of the different types of diabetes. It then gives a classification of the diabetes market, and then provides a brief description of different classes of diabetes pharmaceuticals. The market overview section provides an insight into the global market and then moves on to the Indian market, highlighting the market size and growth. It also provides a global diabetes map.

An analysis of the drivers explains the factors for growth of the industry including increasing diabetes cases, introduction of newer and better drugs, increasing aging population and increase in health insurance policies. The key challenges include price regulation in the insulin market, competition from use of complementary and alternative medicines and maintenance of a healthy lifestyle to avoid diabetes.

The Government initiatives section gives a brief description of the different diabetes programmes undertaken by the Government.

A brief overview of the drug regulations and patents is presented in the next section. It focuses on the different stages of clinical trial that a drug must pass through. Drug regulations in India and drugs approved for marketing have been provided. The section also provides a list of important patent approvals for diabetes drugs.

The competition section gives overview of pharmaceutical companies in the country operating in the anti diabetic pharmaceutical and insulin segments along with segmentation of players in respect to production of oral drugs and insulin. Thereafter, the report highlights the features of the major players operating in the market in detail. It includes an elaborate profile of the major players in the market along with their financial analysis. Porters Five Forces Analysis has been incorporated for a brief but effective understanding of the market scenario.

The strategic recommendations section focuses on some effective strategic decisions which can be taken up by companies to increase their market shares.

For more details on the content of each report and ordering information please contact:
Tamojit Roy
Netscribes India Pvt Ltd
Kalyan Banga
91 3340646215